Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: OJY3SK9H5F

Structure

InChI Key YLFZHHDVRSYTKT-NRFANRHFSA-N
Smile CCOCc1cc(OC)c(-c2ccc(C[C@H](NC(=O)c3c(F)cccc3F)C(=O)O)cc2)c(OC)c1
InChI
InChI=1S/C27H27F2NO6/c1-4-36-15-17-13-22(34-2)24(23(14-17)35-3)18-10-8-16(9-11-18)12-21(27(32)33)30-26(31)25-19(28)6-5-7-20(25)29/h5-11,13-14,21H,4,12,15H2,1-3H3,(H,30,31)(H,32,33)/t21-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C27H27F2NO6
Molecular Weight 499.51
AlogP 4.61
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 11.0
Polar Surface Area 94.09
Molecular species ACID
Aromatic Rings 3.0
Heavy Atoms 36.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Integrin alpha-4/beta-1 antagonist PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Multiple Sclerosis 2 D009103 ClinicalTrials
Multiple Sclerosis, Relapsing-Remitting 1 D020529 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 402567-16-2
ChEMBL CHEMBL2104967
DrugBank DB12732
EPA CompTox DTXSID00433031
FDA SRS OJY3SK9H5F
PubChem 9935681
SureChEMBL SCHEMBL918399
ZINC ZINC000030691369